- Home
- UHS vs DVA Comparison
UHS vs DVA Comparison
Compare UHS & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- DVA
- Stock Information
- Founded
- UHS 1978
- DVA 1994
- Country
- UHS United States
- DVA United States
- Employees
- UHS N/A
- DVA N/A
- Industry
- UHS Hospital/Nursing Management
- DVA Misc Health and Biotechnology Services
- Sector
- UHS Health Care
- DVA Health Care
- Exchange
- UHS Nasdaq
- DVA Nasdaq
- Market Cap
- UHS 10.9B
- DVA 9.4B
- IPO Year
- UHS N/A
- DVA 1995
- Fundamental
- Price
- UHS $187.44
- DVA $127.93
- Analyst Decision
- UHS Hold
- DVA Hold
- Analyst Count
- UHS 14
- DVA 3
- Target Price
- UHS $214.46
- DVA $154.67
- AVG Volume (30 Days)
- UHS 679.8K
- DVA 670.5K
- Earning Date
- UHS 10-23-2025
- DVA 10-28-2025
- Dividend Yield
- UHS 0.43%
- DVA N/A
- EPS Growth
- UHS 39.27
- DVA 8.72
- EPS
- UHS 18.95
- DVA 10.20
- Revenue
- UHS $16,460,285,000.00
- DVA $13,161,328,000.00
- Revenue This Year
- UHS $9.67
- DVA $5.96
- Revenue Next Year
- UHS $4.93
- DVA $3.54
- P/E Ratio
- UHS $9.91
- DVA $12.56
- Revenue Growth
- UHS 9.61
- DVA 5.09
- 52 Week Low
- UHS $152.33
- DVA $126.07
- 52 Week High
- UHS $243.25
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- UHS 57.73
- DVA 35.46
- Support Level
- UHS $180.55
- DVA $131.77
- Resistance Level
- UHS $193.13
- DVA $137.58
- Average True Range (ATR)
- UHS 4.45
- DVA 2.73
- MACD
- UHS -0.12
- DVA -0.72
- Stochastic Oscillator
- UHS 56.33
- DVA 3.56
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.